These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9317021)
1. Enhancement of neutrophil-mediated killing of Plasmodium falciparum asexual blood forms by fatty acids: importance of fatty acid structure. Kumaratilake LM; Ferrante A; Robinson BS; Jaeger T; Poulos A Infect Immun; 1997 Oct; 65(10):4152-7. PubMed ID: 9317021 [TBL] [Abstract][Full Text] [Related]
2. GM-CSF-induced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: synergistic effects of GM-CSF and TNF. Kumaratilake LM; Ferrante A; Jaeger T; Rzepczyk C Parasite Immunol; 1996 Mar; 18(3):115-23. PubMed ID: 9223165 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor primes neutrophils to kill Staphylococcus aureus by an oxygen-dependent mechanism and Plasmodium falciparum by an oxygen-independent mechanism. Kowanko IC; Ferrante A; Clemente G; Kumaratilake LM Infect Immun; 1996 Aug; 64(8):3435-7. PubMed ID: 8757889 [TBL] [Abstract][Full Text] [Related]
5. The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects. Kumaratilake LM; Ferrante A; Rzepczyk C J Immunol; 1991 Jan; 146(2):762-7. PubMed ID: 1898962 [TBL] [Abstract][Full Text] [Related]
6. Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Kumaratilake LM; Ferrante A; Jaeger T; Rzepczyk CM Infect Immun; 1992 Sep; 60(9):3731-8. PubMed ID: 1500183 [TBL] [Abstract][Full Text] [Related]
7. Docosahexanoic acid (22:6, n-3) but not eicosapentaenoic acid (20:5, n-3) can induce neutrophil-mediated injury of cultured endothelial cells: involvement of neutrophil elastase. Bates EJ; Ferrante A; Harvey DP; Nandoskar M; Poulos A J Leukoc Biol; 1993 Dec; 54(6):590-8. PubMed ID: 8245712 [TBL] [Abstract][Full Text] [Related]
8. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages). Ferrante A; Kumaratilake L; Rzepczyk CM; Dayer JM Immunol Lett; 1990 Aug; 25(1-3):179-87. PubMed ID: 2126525 [TBL] [Abstract][Full Text] [Related]
14. A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice. Kumaratilake LM; Rathjen DA; Mack P; Widmer F; Prasertsiriroj V; Ferrante A J Clin Invest; 1995 May; 95(5):2315-23. PubMed ID: 7738194 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha modulates the selective interference of hypnotics and sedatives to suppress N-formyl-methionyl-leucyl-phenylalanine-induced oxidative burst formation in neutrophils. Weiss M; Buhl R; Medve M; Schneider EM Crit Care Med; 1997 Jan; 25(1):128-34. PubMed ID: 8989188 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of the neutrophil response to Naegleria fowleri by tumor necrosis factor alpha. Ferrante A Infect Immun; 1989 Oct; 57(10):3110-5. PubMed ID: 2777375 [TBL] [Abstract][Full Text] [Related]
18. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria. Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929 [TBL] [Abstract][Full Text] [Related]
19. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Thies F; Miles EA; Nebe-von-Caron G; Powell JR; Hurst TL; Newsholme EA; Calder PC Lipids; 2001 Nov; 36(11):1183-93. PubMed ID: 11795850 [TBL] [Abstract][Full Text] [Related]
20. Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. Kumaratilake LM; Robinson BS; Ferrante A; Poulos A J Clin Invest; 1992 Mar; 89(3):961-7. PubMed ID: 1541684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]